A Study of Subcutaneous RoActemra/Actemra (Tocilizumab) as Monotherapy or in Combination With Methotrexate or Other Non-Biologic DMARDs in Patients With Active Rheumatoid Arthritis
Clinical trial NCT01995201 · COMPLETED
Trial details
- NCT number
- NCT01995201
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2013-09-01
- Primary completion
- 2015-07-01
- Enrollment
- 401
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.